These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32578983)

  • 1. Copper Complexes with 1,10-Phenanthroline Derivatives: Underlying Factors Affecting Their Cytotoxicity.
    Nunes P; Correia I; Marques F; Matos AP; Dos Santos MMC; Azevedo CG; Capelo JL; Santos HM; Gama S; Pinheiro T; Cavaco I; Pessoa JC
    Inorg Chem; 2020 Jul; 59(13):9116-9134. PubMed ID: 32578983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of vanadium complexes with 1,10-phenanthroline ligands, quo vadis? Fate of complexes in cell media and cancer cells.
    Nunes P; Correia I; Cavaco I; Marques F; Pinheiro T; Avecilla F; Pessoa JC
    J Inorg Biochem; 2021 Apr; 217():111350. PubMed ID: 33477088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer.
    Iglesias S; Alvarez N; Torre MH; Kremer E; Ellena J; Ribeiro RR; Barroso RP; Costa-Filho AJ; Kramer MG; Facchin G
    J Inorg Biochem; 2014 Oct; 139():117-23. PubMed ID: 25033418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.
    Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I
    J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
    Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
    J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA interaction of [Cu(dmp)(phen-dion)] (dmp=4,7 and 2,9 dimethyl phenanthroline, phen-dion=1,10-phenanthroline-5,6-dion) complexes and DNA-based electrochemical biosensor using chitosan-carbon nanotubes composite film.
    Kashanian S; Khodaei MM; Roshanfekr H; Peyman H
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Oct; 114():642-9. PubMed ID: 23811151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ni(ii)/Cu(ii)/Zn(ii) 5,5-diethylbarbiturate complexes with 1,10-phenanthroline and 2,2'-dipyridylamine: synthesis, structures, DNA/BSA binding, nuclease activity, molecular docking, cellular uptake, cytotoxicity and the mode of cell death.
    Yilmaz VT; Icsel C; Suyunova F; Aygun M; Aztopal N; Ulukaya E
    Dalton Trans; 2016 Jun; 45(25):10466-79. PubMed ID: 27263797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.
    Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M
    J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4).
    Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A
    J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Spectral Characterization, DNA/ Protein Binding, DNA Cleavage, Cytotoxicity, Antioxidative and Molecular Docking Studies of Cu(II)Complexes Containing Schiff Base-bpy/Phen Ligands.
    Anupama B; Aruna A; Manga V; Sivan S; Sagar MV; Chandrashekar R
    J Fluoresc; 2017 May; 27(3):953-965. PubMed ID: 28097460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu(ii)/Zn(ii) complexes containing a carbohydrazone ligand.
    Parsekar SU; Velankanni P; Sridhar S; Haldar P; Mate NA; Banerjee A; Sudhadevi Antharjanam PK; Koley AP; Kumar M
    Dalton Trans; 2020 Mar; 49(9):2947-2965. PubMed ID: 32073070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity and photocatalytic properties of a naphthyl-imidazo phenanthroline (HNAIP) ligand and its [Ir(ppy)
    Rubio AR; Fidalgo J; Martin-Vargas J; Pérez-Arnaiz C; Alonso-Torre SR; Biver T; Espino G; Busto N; García B
    J Inorg Biochem; 2020 Feb; 203():110885. PubMed ID: 31731049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro DNA and BSA-binding, cell imaging and anticancer activity against human carcinoma cell lines of mixed ligand copper(II) complexes.
    Anjomshoa M; Torkzadeh-Mahani M
    Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():390-402. PubMed ID: 26057093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.
    Pivetta T; Isaia F; Verani G; Cannas C; Serra L; Castellano C; Demartin F; Pilla F; Manca M; Pani A
    J Inorg Biochem; 2012 Sep; 114():28-37. PubMed ID: 22687563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent mixed ligand copper(II) complexes of anthracene-appended Schiff bases: studies on DNA binding, nuclease activity and cytotoxicity.
    Jaividhya P; Ganeshpandian M; Dhivya R; Akbarsha MA; Palaniandavar M
    Dalton Trans; 2015 Jul; 44(26):11997-2010. PubMed ID: 26076117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
    Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
    Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity.
    Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF
    J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, structure information, DNA/BSA binding affinity and in vitro cytotoxic studies of mixed ligand copper(II) complexes containing a phenylalanine derivative and diimine co-ligands.
    Annaraj B; Balakrishnan C; Neelakantan MA
    J Photochem Photobiol B; 2016 Jul; 160():278-91. PubMed ID: 27155593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New binary copper(II) complexes containing intercalating ligands: DNA interactions, an unusual static quenching mechanism of BSA and cytotoxic activities.
    İnci D; Aydın R; Vatan Ö; Zorlu Y; Çinkılıç N
    J Biomol Struct Dyn; 2018 Nov; 36(15):3878-3901. PubMed ID: 29132253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.